Athena San Diego
Prev MonthPrev Month Next MonthNext Month
LSIG | Fireside with S Johnson & L Walters-Hoffert
Morrison Foerster
12531 High Bluff Dr # 100
San Diego, CALIFORNIA 92130
United States

View additional information
Tuesday, April 09, 2019, 5:30 PM - 8:00 PM PDT
Category: SIG Events

Athena's Life Sciences Special Interest Group (LSIG) Committee Presents |
Fireside Chat with Daré Bioscience's Sabrina Johnson and Lisa Walters-Hoffert

How do women jump from the bench to the C-suite? How do women translate science background and technical training into business acumen? The life sciences job opportunities are sizzling hot and Athena's Fireside Chat will prepare those ready to leverage their science background and advance up the corporate ladder.

On April 9, join Athena and its Life Sciences Special Interest Group (LSIG) Committee as they feature Sabrina Johnson, President & CEO of Daré Bioscience: DARE (NASDAQ). Here’s what you can expect to learn:

  • Why and how a biochemist transitioned from the bench of big pharma to raising $170M in capital as  CEO of a life sciences company
  • How Sabrina persuaded hiring managers that she could successfully transition to a business role 
  • How Sabrina and Lisa obtained financial fluency and business savvy 
  • The challenges they overcame and the strategies they deployed
  • What they look for in job candidates today as they grows their publicly traded life sciences company
Register Now

Meet Our Special Guests

Sabrina Johnson
President and CEO | Daré Bioscience
Ms. Johnson founded Daré Bioscience Operations, Inc. in 2015 and has served as President, CEO and a member of the Board of Directors since its inception and following its business combination with Cerulean Pharma Inc. on July 19, 2017, when the Company was renamed Daré Bioscience, Inc.  Ms. Johnson is a life sciences executive committed to advancing improvements in women’s healthcare. Previously, Ms. Johnson served as President of WomanCare Global Trading, a specialty pharmaceutical company in female reproductive healthcare with commercial product distribution in over 100 countries, from October of 2014 to May of 2015, and Chief Financial Officer and Chief Operating Officer from July 2013 to October 2014. Ms. Johnson provided financial consulting services to the WomanCare Global family of companies, including the United Kingdom-based non-profit division, from November 2012 to July 2013. From 2002 until its sale in 2010, Ms. Johnson served as Chief Financial Officer of Cypress Bioscience, Inc., a publicly-traded pharmaceutical company, and in addition served as its Chief Operating Officer from 2008 until its sale in 2010. Ms. Johnson began her career in the biotechnology industry as a research scientist with Baxter Healthcare, Hyland Division, working on their recombinant factor VIII program, and later held marketing and sales positions with Advanced Tissue Sciences and Clonetics Corporation.
Ms. Johnson currently serves on the boards of Aethlon Medical, Inc., a publicly-traded company developing immunotherapeutic technologies to combat infectious disease and cancer; the YWCA of San Diego County as Past President, PPPSW, Athena San Diego, and the Clearity Foundation as Vice Chair. Additionally. Ms. Johnson serves on the Board of Advisors of Tulane University School of Science & Engineering, Chair of University of California San Diego (UCSD) Librarian’s Advisory Board, and on the Audit Committee of Project Concern International. Ms. Johnson is also Immediate Past Co-President of Women Give San Diego, which funds non-profit organizations serving women and girls in San Diego.
Ms. Johnson has a Masters of International Management degree with honors from the American Graduate School of International Management (Thunderbird), a MSc in Biochemical Engineering from the University of London, University College London and a BSc in Biomedical Engineering from Tulane University, where she graduated magna cum laude. 

Lisa Walters-Hoffert
Chief Financial Officer | Daré Bioscience
Ms. Walters-Hoffert co-founded Daré Bioscience Operations, Inc. in 2015 and served as the company’s Chief Business Officer.  Following the company’s business combination with Cerulean Pharma Inc. on July 19, 2017, she became the Chief Financial Officer of the renamed company, Daré Bioscience, Inc. During the 25 years prior to joining the team, Ms. Walters-Hoffert was an investment banker focused primarily on raising equity capital for, and providing advisory services to, small-cap public companies. From 2003 to 2015, Ms. Walters-Hoffert worked for Roth Capital Partners, an investment banking firm focused on providing investment banking services to such companies, most recently serving as Managing Director in the Investment Banking Division, overseeing the firm’s San Diego office and its activities with respect to medical device, diagnostic and specialty pharma companies. At Roth Capital Partners, Ms. Walters-Hoffert trained and managed transaction deal teams and was responsible for the oversight of all aspects of transactions, including due diligence, internal communications with sales forces and external communications with institutional investors, among others. Ms. Walters-Hoffert has held various positions in the corporate finance and investment banking divisions of Citicorp Securities in San José, Costa Rica and Oppenheimer & Co, Inc. in New York City, New York.
Ms. Walters-Hoffert has served as a member of the Board of Directors of the San Diego Venture Group, as Past Chair of the UCSD Librarian’s Advisory Board and as Immediate Past Chair of the Board of Planned Parenthood of the Pacific Southwest. Ms. Walters-Hoffert graduated from Duke University with a BS in Management Sciences, magna cum laude.

Register

Empowered by